GlycoNex Competitors and Similar CompaniesClear all
GlycoNex's competitors and similar companies include Oncopeptides and Taiho Oncology.
 GlycoNex GlycoNex (台灣醣聯生技醫藥股) is a company developing cancer drugs utilizing glycosphingolipid antigen and human monoclonal antibody technologies. |  Taiho Oncology Taiho Oncology is a pharmaceutical company engaged in the discovery and development of cancer treatments. | ||
Founding Date | Founding Date 2001 | Founding Date 2000 | Founding Date 2002 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations TW HQ | Locations Stockholm, SE HQ Stockholm, SE Los Altos, US Mountain View, US Waltham, US | Locations Singapore, SG HQ Oakville, CA Chiyoda City, JP Birmingham, GB Menlo Park, US Princeton, US |
Employees | Employees N/A | Employees 80 | Employees 4191% increase |
Financial | |||
Revenue (est.) | Revenue (est.) NT$37.9m (FY, 2025) | Revenue (est.) kr71.1m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods NT$14.3m (FY, 2025) | Cost of goods kr2.5m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit NT$36.7m (FY, 2025) | Gross profit kr72m (FY, 2025) | Gross profit N/A |
Net income | Net income (NT$235.2m) (FY, 2025) | Net income (kr249.6m) (FY, 2025) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
Oncopeptides
HQ
Stockholm, SE
Employees
80
Oncopeptides is a clinical development pharmaceutical company.
View companyTaiho Oncology
HQ
Singapore, SG
Taiho Oncology is a pharmaceutical company engaged in the discovery and development of cancer treatments.
View company